UY32337A - Compuesto que contiene nicotina, método de preparación y su uso para la preparación de compuesto farmacéutico - Google Patents

Compuesto que contiene nicotina, método de preparación y su uso para la preparación de compuesto farmacéutico

Info

Publication number
UY32337A
UY32337A UY0001032337A UY32337A UY32337A UY 32337 A UY32337 A UY 32337A UY 0001032337 A UY0001032337 A UY 0001032337A UY 32337 A UY32337 A UY 32337A UY 32337 A UY32337 A UY 32337A
Authority
UY
Uruguay
Prior art keywords
preparation
nicotine
compound
containing nicotine
pharmaceutically acceptable
Prior art date
Application number
UY0001032337A
Other languages
English (en)
Inventor
Franz Alexander
Original Assignee
Siegfried Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ltd filed Critical Siegfried Ltd
Publication of UY32337A publication Critical patent/UY32337A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Abstract

La presente invención se refiere a un producto que contiene nicotina que comprende un sustrato polimérico farmacéuticamente aceptable, el cual es capaz de unirse a cationes, nicotina o un derivado de nicotina farmacéuticamente aceptables, y cationes inorgánicos farmacéuticamente aceptables. También se refiere a un método para la preparación de dicho producto que contiene nicotina y a su uso para la preparación de un producto farmacéutico.
UY0001032337A 2008-12-19 2009-12-17 Compuesto que contiene nicotina, método de preparación y su uso para la preparación de compuesto farmacéutico UY32337A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08022123A EP2198865B1 (en) 2008-12-19 2008-12-19 Nicotine-containing product

Publications (1)

Publication Number Publication Date
UY32337A true UY32337A (es) 2010-07-30

Family

ID=40602533

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032337A UY32337A (es) 2008-12-19 2009-12-17 Compuesto que contiene nicotina, método de preparación y su uso para la preparación de compuesto farmacéutico

Country Status (17)

Country Link
US (1) US9585967B2 (es)
EP (2) EP2392331A1 (es)
AR (1) AR074770A1 (es)
AT (1) ATE533487T1 (es)
AU (1) AU2009328589B2 (es)
CA (1) CA2734403C (es)
DK (1) DK2198865T3 (es)
ES (1) ES2377673T3 (es)
HR (1) HRP20110954T1 (es)
MX (1) MX2011003942A (es)
NZ (1) NZ591209A (es)
PL (1) PL2198865T3 (es)
PT (1) PT2198865E (es)
SI (1) SI2198865T1 (es)
UY (1) UY32337A (es)
WO (1) WO2010069507A1 (es)
ZA (1) ZA201101124B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11911375B2 (en) * 2020-11-16 2024-02-27 Fertin Pharma A/S Solid oral nicotine formulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
GB1332503A (en) * 1970-10-15 1973-10-03 British American Tobacco Co Smoking compositions
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
IT1104351B (it) * 1978-06-14 1985-10-21 Muzzarelli Riccardo Il complesso glucano chitosano il metodo della sua produzione a partire da muffe funghi e lieviti e i suoi usi
GB9310412D0 (en) 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
GB2385288A (en) 2002-01-18 2003-08-20 Advanced Phytonics Ltd Preparing a resinate.
US6586449B1 (en) 2002-05-28 2003-07-01 Cambrex Charles City, Inc. Nicotine-containing, controlled release composition and method
US20050123502A1 (en) * 2003-10-07 2005-06-09 Chan Shing Y. Nicotine containing oral compositions
EP1696923B1 (en) 2003-12-02 2009-08-19 Fertin Pharma A/S Nicotine delivery product and method for producing
US20070269386A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
PT2177213E (pt) * 2008-09-17 2013-02-21 Siegfried Ltd Granulado contendo nicotina

Also Published As

Publication number Publication date
US9585967B2 (en) 2017-03-07
ATE533487T1 (de) 2011-12-15
AU2009328589B2 (en) 2012-12-06
MX2011003942A (es) 2011-05-19
US20110207782A1 (en) 2011-08-25
PT2198865E (pt) 2012-02-07
ZA201101124B (en) 2012-05-30
SI2198865T1 (sl) 2012-02-29
HRP20110954T1 (hr) 2012-01-31
NZ591209A (en) 2012-11-30
CA2734403A1 (en) 2010-06-24
AU2009328589A1 (en) 2010-06-24
PL2198865T3 (pl) 2012-04-30
ES2377673T3 (es) 2012-03-29
WO2010069507A1 (en) 2010-06-24
DK2198865T3 (da) 2012-01-16
EP2392331A1 (en) 2011-12-07
CA2734403C (en) 2013-05-14
EP2198865A1 (en) 2010-06-23
EP2198865B1 (en) 2011-11-16
AR074770A1 (es) 2011-02-09

Similar Documents

Publication Publication Date Title
WO2010111406A3 (en) Purine derivatives useful as anti - cancer agents
EA201170772A1 (ru) Органические соединения
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
BRPI0917705A2 (pt) composto, pró-droga, composição farmacêutica, método para tratar ou prevenir uma doença ou condição, e, uso do composto
CL2007003802A1 (es) Compuestos derivados de piperidina, inhibidores de la sintasa de acidos grasos; procedimiento de preparacion de dichos compuestos; y su uso para tratar la obesidad o el sobrepeso.
BRPI0909768A2 (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto""composto, composição farmacêutica, método para o tratamento ou orevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto
AR110128A2 (es) Compuesto del grupo de las 3-(imidazoil)-pirazolo[3,4-b]piridinas, composición farmacéutica que lo comprende y método para preparar el mismo
BRPI0815190A2 (pt) Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
WO2009034119A8 (en) Improved derivatives of amylin
CL2007003176A1 (es) Compuestos derivados de nicotinamida, inhibidores de 11betahsd1; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar el sindrome metabolico, la diabetes tipo 2, obesidad o aterosclerosis.
CO6280490A2 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
WO2009156462A3 (en) Organic compounds
GT201400111A (es) Triazolopiridinas sustituidas
WO2008132600A3 (en) Trpv1 antagonists and uses thereof
WO2009023434A3 (en) Method for stabilizing phenylephrine
CL2007003100A1 (es) Compuestos derivados de pirimidina, inhibidores de cisteina proteasa; procesos de preparacion; sales de los compuestos; composicion farmaceutica; y uso para el tratamiento de la malaria.
CL2016002833A1 (es) Composición fungicida que comprende un derivado de benzoilpiridina y un segundo compuesto fungicida, y método para el control de las enfermedades de las plantas.
CL2011001331A1 (es) Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo.
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
BRPI0912539A2 (pt) composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
HN2011001247A (es) Inhibidores de cinana akt y p70 s6
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20190117